Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors

Details for Australian Patent Application No. 2005217199 (hide)

Owner Merz Pharma GmbH & Co. KgaA

Inventors Danysz, Wojciech; Weil, Tanja; Kalvinsh, Ivars; Kauss, Valerjans; Vanejevs, Maksims; Henrich, Markus; Jirgensons, Aigars; Parsons, Christopher Graham Raphael; Jaunzeme, Ieva

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005217199

PCT Pub. Number WO2005/082856

Priority 60/548,788 27.02.04 US

Filing date 25 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 26 June 2008

International Classifications

A61K 31/47 (2006.01) - Quinolines

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/227 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/36 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/54 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 221/06 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 221/22 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 407/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/082856 Priority application(s): WO2005/082856

26 June 2008 Application Accepted

  Published as AU-B-2005217199

23 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005217200-Materials and methods for treatment of allergic disease

2005217198-Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity